Tango Therapeutics, Inc.
TNGX
$18.00
$0.704.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 343.14M | 152.81M | 180.79M | 216.72M | 257.92M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.19M | 10.54M | 8.89M | 7.78M | 8.43M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 428.00K | 428.00K | 428.00K | 428.00K | -- |
| Total Current Assets | 353.76M | 163.78M | 190.10M | 224.93M | 266.34M |
|
|
|||||
| Total Current Assets | 353.76M | 163.78M | 190.10M | 224.93M | 266.34M |
| Net Property, Plant & Equipment | 42.49M | 43.93M | 45.34M | 47.24M | 47.58M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.94M | 2.43M | 2.45M | 2.14M | 2.57M |
| Total Assets | 398.69M | 210.14M | 237.89M | 274.31M | 316.49M |
|
|
|||||
| Total Accounts Payable | 1.18M | 2.23M | 2.61M | 3.24M | 1.60M |
| Total Accrued Expenses | 16.47M | 11.38M | 9.51M | 8.40M | 14.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.74M | 3.10M | 2.53M | 2.82M | 2.45M |
| Total Finance Division Other Current Liabilities | 1.29M | 1.73M | 25.37M | 21.46M | 19.35M |
| Total Other Current Liabilities | 1.29M | 1.73M | 25.37M | 21.46M | 19.35M |
| Total Current Liabilities | 21.68M | 18.44M | 40.03M | 35.92M | 38.17M |
|
|
|||||
| Total Current Liabilities | 21.68M | 18.44M | 40.03M | 35.92M | 38.17M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 30.83M | 31.66M | 32.47M | 34.12M | 34.04M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 30.44M | 37.51M | 44.77M |
| Total Liabilities | 52.51M | 50.11M | 102.94M | 107.55M | 116.98M |
|
|
|||||
| Common Stock & APIC | 949.11M | 724.31M | 715.15M | 708.00M | 700.74M |
| Retained Earnings | -603.15M | -564.40M | -580.29M | -541.43M | -501.56M |
| Treasury Stock & Other | 224.00K | 121.00K | 94.00K | 194.00K | 336.00K |
| Total Common Equity | 346.18M | 160.03M | 134.95M | 166.76M | 199.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 346.18M | 160.03M | 134.95M | 166.76M | 199.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 346.18M | 160.03M | 134.95M | 166.76M | 199.52M |
|
|
|||||